KALEIDO BIOSCIENCES, INC. Shareholders' Equity
KALEIDO BIOSCIENCES, INC. had Shareholders' Equity of $10.61 million as of 2021-12-31, per its 10-K filed 2022-04-01.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2022-04-01
- 2021-12-31: Stockholders' Equity Attributable to Parent $10.61M.
- 2021-09-30: Stockholders' Equity Attributable to Parent $29.20M.
- 2021-06-30: Stockholders' Equity Attributable to Parent $50.27M.
- 2021-03-31: Stockholders' Equity Attributable to Parent $71.77M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2021-12-31 | $10.61M 10-K · filed 2022-04-01 |
| 2021-09-30 | $29.20M 10-Q · filed 2021-11-01 |
| 2021-06-30 | $50.27M 10-Q · filed 2021-11-01 |
| 2021-03-31 | $71.77M 10-Q · filed 2021-11-01 |
| 2020-12-31 | $20.50M 10-K · filed 2022-04-01 |
| 2020-09-30 | $35.90M 10-Q · filed 2021-11-01 |
| 2020-06-30 | $51.32M 10-Q · filed 2021-11-01 |
| 2020-03-31 | $33.62M 10-Q · filed 2021-11-01 |
| 2019-12-31 | $48.88M 10-K · filed 2022-04-01 |
| 2019-09-30 | $66.04M 10-Q · filed 2020-11-02 |
| 2019-06-30 | $84.63M 10-Q · filed 2020-11-02 |
| 2019-03-31 | $107.14M 10-Q · filed 2020-11-02 |
| 2018-12-31 | -$96.24M 10-K · filed 2021-03-03 |
| 2018-09-30 | -$78.02M 10-Q · filed 2019-10-30 |
| 2018-06-30 | -$65.33M 10-Q · filed 2019-10-30 |
| 2018-03-31 | -$54.05M 10-Q · filed 2019-10-30 |
| 2017-12-31 | -$43.68M 10-K · filed 2020-03-02 |